Details for 2018203320

Up to date per 03.04.2026

Actions

Title / Product Name

19-NOR-C3,3-DISUBSTITUIERTES C21-N-PYRAZOLYLSTEROID ZUR THERAPEUTISCHEN BEHANDLUNG

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018203320

EP Publication Number

3498725

E-Number

1400429

Language

PCT Number

Publication Date

19.06.2019 A

09.06.2021 B1

Registration Date

09.06.2021

AT Publication Date

15.06.2021

Application Date

17.04.2014

Registration Number

Priorities

17.04.2013

PCT/CN2013/074323

IPC

C07J 43/00 20060101AFI20201009BHEP

Maximum Duration of Protection

17.04.2034

Owner

Sage Therapeutics, Inc.215 First Street Cambridge, MA 02142US

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT

Inventor

BOTELLA, Gabriel Martinez17 Parmenter Road Wayland, Massachusetts 01778US

HARRISON, Boyd, L.9 Wheatston Court Princeton Junction, New Jersey 08550US

ROBICHAUD, Albert, Jean3 Riverview Court Ringoes, New Jersey 08551US

SALITURO, Francesco G.25 Baker Drive Marlborough, Massachusetts 01752US

BERESIS, Richard ThomasApartment 2504, Building 1 199 Shimen 2 Road Shanghai, 200040CN

Information about Fees